Who pays +0.010% funding to hold a coin that just did +18% in a day? $INJ longs do. 🧾
The development is dated: on Wednesday, October 14, Injective CEO Eric Chen met officials from the White House, the SEC and the CFTC to push tokenization and on-chain finance inside US rules. Same week, a new cross-chain USDC route and an institutional validator joined the network.
Case for strength: $INJ at 8.996 USDT sits in the top quarter of its 7.584 to 9.413 range, and the +18.37% day lands on a +30.31% week, so this reads as continuation, not a one-day pop. Bitcoin is flat at 81,892 with -1.36% on the week; the move is Injective's own.
Case for weakness: that +30% week means most of the headline is priced, the print is already 4% off the 24h high, and +0.010% is the richest funding on the top-volume list, triple what Bitcoin longs pay. With $TIA up +24.11% on the same tape, this is a rotation day, and rotations move on. 🧭
Funding backs the weakness read today: late longs are the ones paying, and 49M USDT of volume is thin next to the top ten. A hold above 9.413 on more volume would flip that; 7.584 is the level I'm watching, not a target.
Is +0.010% a fair price to be long INJ after a +30% week, or is the meeting already in the price?
#INJ #FundingRates #Tokenization #Injective
The development is dated: on Wednesday, October 14, Injective CEO Eric Chen met officials from the White House, the SEC and the CFTC to push tokenization and on-chain finance inside US rules. Same week, a new cross-chain USDC route and an institutional validator joined the network.
Case for strength: $INJ at 8.996 USDT sits in the top quarter of its 7.584 to 9.413 range, and the +18.37% day lands on a +30.31% week, so this reads as continuation, not a one-day pop. Bitcoin is flat at 81,892 with -1.36% on the week; the move is Injective's own.
Case for weakness: that +30% week means most of the headline is priced, the print is already 4% off the 24h high, and +0.010% is the richest funding on the top-volume list, triple what Bitcoin longs pay. With $TIA up +24.11% on the same tape, this is a rotation day, and rotations move on. 🧭
Funding backs the weakness read today: late longs are the ones paying, and 49M USDT of volume is thin next to the top ten. A hold above 9.413 on more volume would flip that; 7.584 is the level I'm watching, not a target.
Is +0.010% a fair price to be long INJ after a +30% week, or is the meeting already in the price?
#INJ #FundingRates #Tokenization #Injective